Monkeypox vaccine maker raises concerns about plan to split doses ...Middle East

The Hill - News
Monkeypox vaccine maker raises concerns about plan to split doses
The CEO of the company that makes the only vaccine approved by the Food and Drug Administration (FDA) to prevent monkeypox told Biden administration health officials he was concerned about a new strategy to split doses and change the way the vaccine is injected. In a letter shared with The Hill, Bavarian Nordic CEO Paul Chaplin said the company has "some reservations" about the new approach, "due to the very limited safety data available," as well as the fact that more people experienced adverse reactions after vaccination. "This may have a negative impact on vaccine uptake and coverage," Chaplin wrote. The letter to FDA Commissioner Robert Califf and Health and Human Services S

Hence then, the article about monkeypox vaccine maker raises concerns about plan to split doses was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Monkeypox vaccine maker raises concerns about plan to split doses )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News